Emily Pimblett Eliem Therapeutics, Inc. (ELYM) insider trading activity

Emily Pimblett is SVP, Finance & CAO of Eliem Therapeutics, Inc.. Currently has a direct ownership of 15,130 shares of ELYM, which is worth approximately $62,184. The most recent transaction as insider was on Mar 20, 2025, when has been sold 1,199 shares (Common Stock) at a price of $1.31 per share, resulting in proceeds of $1,570. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.1K

33.55% 3M change

n/a 12M change

Total Value Held $62,184

Emily Pimblett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 20 2025	SELL Open market or private sale	$1,570 $1.31 p/Share	1,199 Reduced 7.34%	15,130 Common Stock
Mar 18 2025	BUY Exercise of conversion of derivative security	-	5,000 Added 23.44%	16,329 Common Stock
Dec 19 2024	SELL Open market or private sale	$2,494 $2.02 p/Share	1,235 Reduced 9.83%	11,329 Common Stock
Dec 18 2024	BUY Exercise of conversion of derivative security	-	5,000 Added 28.47%	12,564 Common Stock
Sep 20 2024	SELL Open market or private sale	$9,670 $8.12 p/Share	1,191 Reduced 13.6%	7,564 Common Stock
Sep 18 2024	BUY Exercise of conversion of derivative security	-	5,000 Added 36.35%	8,755 Common Stock
Jun 20 2024	SELL Open market or private sale	$8,976 $7.21 p/Share	1,245 Reduced 24.9%	3,755 Common Stock
Jun 18 2024	BUY Exercise of conversion of derivative security	-	5,000 Added 50.0%	5,000 Common Stock

Emily Pimblett

SVP, Finance & CAO

Wilmington, DE

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELYM shares.

Notify only if

Value

Insider Trading

Get notified when an Eliem Therapeutics, Inc. insider buys or sells ELYM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Eliem Therapeutics, Inc.

Track Activities on ELYM

Account